Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD) [NA]

View source ↗

Summary

Clinical trial evaluating a self-expanding coronary sinus reducer for symptomatic coronary microvascular dysfunction, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Self Expanding Coronary Sinus Reducer

Snippet

Sponsor: VahatiCor, Inc. | Conditions: Angina Pectoris, Myocardial Ischemia | NA | Status: NOT_YET_RECRUITING